Compare ONCO & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONCO | GXAI |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 755.3K | 13.5M |
| IPO Year | 2021 | 2022 |
| Metric | ONCO | GXAI |
|---|---|---|
| Price | $1.21 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 276.1K |
| Earning Date | 06-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.80 | ★ 71.35 |
| EPS | N/A | ★ N/A |
| Revenue | $815,371.00 | ★ $1,933,030.00 |
| Revenue This Year | N/A | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.07 | $1.02 |
| 52 Week High | $7.65 | $2.96 |
| Indicator | ONCO | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 63.94 | 45.40 |
| Support Level | $0.49 | $1.04 |
| Resistance Level | $1.87 | $1.31 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 82.22 | 46.47 |
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.